Marc Tessier-Lavigne
Canadian neuroscientist (born 1959)
Marc Tessier-Lavigne
Marc Trevor Tessier-Lavigne (born December 18, 1959) is a Canadian-American neuroscientist who is the co-founder, CEO, and chair of the AI biotechnology firm Xaira Therapeutics. He is also a biology professor at Stanford University, where he served as its 11th president from 2016 until his resignation in 2023. Tessier-Lavigne was formerly executive vice president for research and the chief scientific officer at Genentech. In 2011, he joined the boards of directors of Agios Pharmaceuticals, Regeneron Pharmaceuticals, and Pfizer. In 2014, he joined the board of Juno Therapeutics, and in 2015 he co-founded Denali Therapeutics and joined its board. Tessier-Lavigne was the 10th president of Rockefeller University in New York City from 2011 to 2016, and a professor at the University of California, San Francisco. In 2022, the Stanford board of trustees opened an investigation into alleged research misconduct by Tessier-Lavigne. The board's investigation found that four papers co-authored by Tessier...
Read on Wikipedia · Image Adam Fagen, CC BY-SA 2.0
Open boosters, collect cards and trade them. Free to play.
Play for free